Skip to main content
. 2013 Mar 26;8(3):e58360. doi: 10.1371/journal.pone.0058360

Table 1. Characteristics of the study population.

Variable All patients Estimation G. Validation Koeln Essen
(n = 267) (n = 170) (n = 97) (n = 183) (n = 84)
Age (years) 43.8±12.1 43.9±11.9 43.7±12.6 44.8±12.6 41.8±10.8
Female n, (%) 141 (52.8) 89 (52.4) 52 (53.6) 70 (38.3) 71 (84.5)
BMI (kg/m2) 37.0±12.7 37.2±13.0 36.6±12.9 29.0±6.1 52.4±7.6
BMI normal/overweight/obese, n 25/79/139 13/53/91 12/26/48 25/79/56 0/0/82
Stage of fibrosis 0/1/2/3/4, n 8/107/130/18/4 7/68/82/11/2 1/39/48/7/2 8/91/63/17/4 0/16/67/1/0
Hypertension n, (%) 112 (41.9) 74 (43.5) 38 (39.6) 73 (39.9) 39 (46.4)
Diabetes n, (%) 53 (19.9) 33 (19.4) 20 (20.6) 19 (10.4) 34 (40.5)
Platelet (1.000/µl) 265.0±80.0 265.4±80.9 264.3±78.7 247.8±71.5 299.0±85.2
AST (IU/ml) 36.8±32.4 34.9±22.8 40.2±44.7 40.9±37.5 27.9±13.5
ALT (IU/ml) 56.6±55.2 54.8±44.4 59.8±70.5 66.4±62.6 35.5±22.8
AST/ALT ratio 0.8±0.3 0.8±0.4 0.7±0.3 0.7±0.3 0.9±0.3
<1,0 n, (%) 214 (80.5) 135 (79.4) 79 (82.3) 154 (84.2) 60 (71.4)
≥1,0 n, (%) 52 (19.5) 35 (20.6) 17 (17.7) 28 (15.4) 24 (28.6)
GGT (IU/ml) 111.4±186.1 128.8±222.7 80.5±82.8 136.8±201.2 56.2±133.4
Total bilirubin (mg/dl) 0.7±0.7 0.7±0.9 0.6±0.4 0.8±0.9 0.5±0.3
Prothrombin time % 101.5±14.6 100.3±15.8 103.8±11.9 103.7±13.5 97.0±15.8
INR 1.0±0.10 1.0±0.1 1.0±0.1 1.0±0.1 0.97±0.1
Creatinine (mg/dl) 0.9±0.7 0.9±0.8 0.8±0.2 0.9±0.8 0.8±0.5
Albumin (g/l) 44.6±3.4 44.8±3.5 44.4±3.3 44.6±3.4 no data
Glucose (mg/dl) 102.8±30.6 103.1±32.6 102.3±26.8 102.8±30.6 110.9±48.7
Alkaline phosphatase (IU/ml) 111.9±52.9 114.1±57.5 108.1±43.8 111.9±52.9 no data
AFP (kU/l) 3.0±1.8 3.1±2.0 2.7±1.4 3.0±1.8 no data

Data are shown as mean ± SD. Percentages (%) are given in brackets and refer to patients inside of respective subset. Abbreviations: BMI  =  body mass index; AST  =  aspartate aminotransferase; ALT  =  alanine aminotransferase; GGT  =  gamma glutamyl transferase; INR  =  International normalized ratio; AFP  =  alpha-fetoprotein.